Jing, Longnian
Wu, Youxuan
Liang, Fa
Jian, Minyu
Bai, Yang
Wang, Yunzhen
Liu, Haiyang
Wang, Anxin
Chen, Xiaolin
Han, Ruquan https://orcid.org/0000-0003-4335-8670
Funding for this research was provided by:
Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201708, DFL20180502)
the Capital Health Research and Development of Special (2022-2-2043)
Article History
Received: 15 March 2022
Accepted: 25 October 2022
First Online: 4 November 2022
Declarations
:
: This study was approved by the Ethics Committee of Beijing Tiantan Hospital affiliated with Capital Medical University (Ethics No. KY 2021–023-02) and registered on ClinicalTrials.gov (NCT04691271) https:/clinicaltrials.gov/ct2/show/NCT04691271?term = NCT04691271&draw = 2&rank = 1. The protocol (vol. 1.4; May 31, 2021) is designed in line with the Standard Protocol Items: Recommendations for Interventional Trials. Informed consent will be obtained from all subjects.
: Not needed.
: The authors declare no competing interests.